Source: Annual Congress 2007 - Assessing the airways: innovation, applications and pitfalls



Rating:

Share or cite this content

Citations should be made in the following way:
R. Zulkarneev, S. Zagidullin, M. Araslanova, V. Bakirova (Ufa, Russian Federation). Increased Tpef/Te ratio reflects restrictive disorders in patients with community acquired pneumonia. Eur Respir J 2007; 30: Suppl. 51, 1115

Member's Comments

No comment yet.

Related content which might interest you: Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Influence of medical comorbidities in patients with community acquired pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Significance of comorbidity in elderly patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006 The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Cardiac diseases in patients with community acquired pneumonia (CAP) Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 The general evaluation of elderly patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004 Comparison of four systems for assessing severity of community acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Postexpiratory pause reflects breathing control in patients with community acquired pneumonia Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 Prevalence of hyponatremia (HN) in children with community acquired pneumonia (CAP) and its relation to disease severity, outcomes Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 Communitty acquired pneumonia in very elderly patients: A characteristical approach Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 Influence of older age on biomarker concentrations in patients with community acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 High prevalence of abnormal lung function is seen in children managed for asthma in primary care Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017 Phenomenon of regional respiratory loop distortion by lung regions in healthy people and patients with community acquired pneumonia and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases Year: 2009